Viatris Inc. (VTRS)
Company Info
US92556V1061
001103120
Nov 16, 2020
Highlights
$9.88B
-$3.18
0.14
$14.32B
$5.33B
-$529.80M
$6.85 - $13.38
$11.75
4.68%
3.60
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Viatris Inc. (VTRS) returned -28.51% year-to-date (YTD) and -17.11% over the past 12 months.
VTRS
-28.51%
17.51%
-28.83%
-17.11%
N/A
N/A
^GSPC (Benchmark)
0.60%
9.64%
-0.54%
11.47%
15.67%
10.79%
Monthly Returns
The table below presents the monthly returns of VTRS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -9.40% | -18.17% | -4.45% | -3.33% | 4.39% | -28.51% | |||||||
| 2024 | 8.68% | 5.10% | -2.53% | -3.10% | -7.36% | 0.28% | 13.45% | 1.20% | -3.89% | -0.09% | 13.88% | -4.89% | 19.68% |
| 2023 | 9.25% | -6.25% | -14.66% | -3.02% | -0.67% | 9.07% | 5.51% | 3.20% | -8.28% | -9.74% | 4.48% | 17.97% | 2.06% |
| 2022 | 10.64% | -25.84% | -1.18% | -5.06% | 20.00% | -14.67% | -7.45% | -0.29% | -10.78% | 18.90% | 10.08% | 0.91% | -14.29% |
| 2021 | -9.34% | -12.60% | -5.93% | -4.80% | 15.40% | -6.23% | -1.54% | 4.76% | -7.38% | -1.48% | -7.01% | 9.91% | -26.12% |
| 2020 | 6.05% | 11.42% | 18.16% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of VTRS is 23, meaning it’s performing worse than 77% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Viatris Inc. (VTRS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Viatris Inc. provided a 5.46% dividend yield over the last twelve months, with an annual payout of $0.48 per share. The company has been increasing its dividends for 3 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Dividend | $0.48 | $0.48 | $0.48 | $0.48 | $0.33 |
Dividend yield | 5.46% | 3.86% | 4.43% | 4.31% | 2.44% |
Monthly Dividends
The table displays the monthly dividend distributions for Viatris Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | |||||||
| 2024 | $0.00 | $0.00 | $0.12 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.48 |
| 2023 | $0.00 | $0.00 | $0.12 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.48 |
| 2022 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.48 |
| 2021 | $0.11 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.11 | $0.00 | $0.33 |
Dividend Yield & Payout
Dividend Yield
Viatris Inc. has a dividend yield of 5.46%, which is quite average when compared to the overall market.
Payout Ratio
Viatris Inc. has a payout ratio of 19.35%, which is below the market average. This means Viatris Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Viatris Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Viatris Inc. was 54.33%, occurring on Apr 10, 2025. The portfolio has not yet recovered.
The current Viatris Inc. drawdown is 44.70%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -54.33% | Jan 4, 2021 | 1073 | Apr 10, 2025 | — | — | — |
| -7.4% | Nov 20, 2020 | 2 | Nov 23, 2020 | 25 | Dec 30, 2020 | 27 |
| -0.92% | Nov 18, 2020 | 1 | Nov 18, 2020 | 1 | Nov 19, 2020 | 2 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Viatris Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Viatris Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 1.6% positive surprise.
Valuation
The Valuation section provides an overview of how Viatris Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for VTRS compared to other companies in the Drug Manufacturers - Specialty & Generic industry. VTRS currently has a PEG ratio of 0.1. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for VTRS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, VTRS has a P/S ratio of 0.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for VTRS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, VTRS has a P/B value of 0.6. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |